Monopar Therapeutics Free Cash Flow (Quarterly) Analysis

Monopar Therapeutics Inc (MNPR)

0.6179 0.00 (0.00%) USD | NASDAQ | May 21, 16:00

0.6179 0.00 (0.00%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	-1.655M
December 31, 2023	-1.546M
September 30, 2023	-1.940M
June 30, 2023	-2.102M
March 31, 2023	-2.271M
December 31, 2022	-1.302M
September 30, 2022	-2.148M
June 30, 2022	-1.311M
March 31, 2022	-2.468M
December 31, 2021	-2.032M
September 30, 2021	-1.941M
June 30, 2021	-1.406M
March 31, 2021	-1.938M
December 31, 2020	-1.241M
September 30, 2020	-1.300M

Date	Value
June 30, 2020	-0.9955M
March 31, 2020	-1.126M
December 31, 2019	-0.6687M
September 30, 2019	-0.6133M
June 30, 2019	-0.7397M
March 31, 2019	-0.996M
December 31, 2018	-0.5192M
September 30, 2018	-0.5996M
June 30, 2018	-0.7529M
March 31, 2018	-0.8088M
December 31, 2017	-0.816M
September 30, 2017	-1.195M
June 30, 2017	-0.3051M
March 31, 2017	-0.3115M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-2.468M

Minimum

Mar 2022

-0.6133M

Maximum

Sep 2019

-1.537M

Average

-1.476M

Median

Free Cash Flow (Quarterly) Benchmarks